215 related articles for article (PubMed ID: 23916135)
1. SPARCL1 suppresses metastasis in prostate cancer.
Xiang Y; Qiu Q; Jiang M; Jin R; Lehmann BD; Strand DW; Jovanovic B; DeGraff DJ; Zheng Y; Yousif DA; Simmons CQ; Case TC; Yi J; Cates JM; Virostko J; He X; Jin X; Hayward SW; Matusik RJ; George AL; Yi Y
Mol Oncol; 2013 Dec; 7(6):1019-30. PubMed ID: 23916135
[TBL] [Abstract][Full Text] [Related]
2. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
[TBL] [Abstract][Full Text] [Related]
4. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
Hurley PJ; Marchionni L; Simons BW; Ross AE; Peskoe SB; Miller RM; Erho N; Vergara IA; Ghadessi M; Huang Z; Gurel B; Park BH; Davicioni E; Jenkins RB; Platz EA; Berman DM; Schaeffer EM
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14977-82. PubMed ID: 22927397
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor SPDEF suppresses prostate tumor metastasis.
Steffan JJ; Koul S; Meacham RB; Koul HK
J Biol Chem; 2012 Aug; 287(35):29968-78. PubMed ID: 22761428
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
Esposito I; Kayed H; Keleg S; Giese T; Sage EH; Schirmacher P; Friess H; Kleeff J
Neoplasia; 2007 Jan; 9(1):8-17. PubMed ID: 17325739
[TBL] [Abstract][Full Text] [Related]
8. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
9. Identifying liver metastasis-related hub genes in breast cancer and characterizing
Chen M; Zheng W; Fang L
PeerJ; 2023; 11():e15311. PubMed ID: 37180578
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.
Puto LA; Brognard J; Hunter T
J Biol Chem; 2015 Jun; 290(25):15406-15420. PubMed ID: 25903140
[TBL] [Abstract][Full Text] [Related]
12. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
[TBL] [Abstract][Full Text] [Related]
13. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis.
Silvertown JD; Ng J; Sato T; Summerlee AJ; Medin JA
Int J Cancer; 2006 Jan; 118(1):62-73. PubMed ID: 16049981
[TBL] [Abstract][Full Text] [Related]
14. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
16. SPARCL1 suppresses cell migration and invasion in renal cell carcinoma.
Ye H; Wang WG; Cao J; Hu XC
Mol Med Rep; 2017 Nov; 16(5):7784-7790. PubMed ID: 28944877
[TBL] [Abstract][Full Text] [Related]
17. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
[TBL] [Abstract][Full Text] [Related]
18. SPARCL1 exhibits different expressions in left- and right-sided colon cancer and is downregulated via DNA methylation.
Hu H; Wu D; Liu X; Yu H; Xu J; Cai W; Huang Y; Bai R; Zhang J; Gu Y; Zheng S; Ge W
Epigenomics; 2021 Aug; 13(16):1269-1282. PubMed ID: 34435512
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
[TBL] [Abstract][Full Text] [Related]
20. Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis.
Gagliardi F; Narayanan A; Gallotti AL; Pieri V; Mazzoleni S; Cominelli M; Rezzola S; Corsini M; Brugnara G; Altabella L; Politi LS; Bacigaluppi M; Falini A; Castellano A; Ronca R; Poliani PL; Mortini P; Galli R
Neurobiol Dis; 2020 Feb; 134():104705. PubMed ID: 31830525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
